Loading
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Oct 2026 for Fennec Pharmaceuticals INC., €8,071. Read the official filing
Filing timeline
BuySaleTerry Evans
Insider track record
Disclosed buys
6
Disclosed sells
0
Signal history
No signal scores available.
Terry Evans: trading record in brief
Terry Evans discloses dealings in Fennec Pharmaceuticals Inc. to SEC (Form 4). The record holds 6 filings, for trades running from 1 June 2026 to 12 October 2026.
On the market, this insider has only ever bought: 6 purchases, €8,071 in total. The totals do not cover 5 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The record was last updated on 14 October 2026 with an open-market purchase (€8,071) in Fennec Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Terry Evans
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
2,326 shares@ CA$5.53Common SharesTSXSEDI:4791124
Canonical exit: 10 Jan 2027 (T+90)
168 sharesCommon SharesTSXSEDI:4783393
Canonical exit: 30 Dec 2026 (T+90)
168 sharesCommon SharesTSXSEDI:4774699
Canonical exit: 3 Dec 2026 (T+90)
168 sharesCommon SharesTSXSEDI:4758109
Canonical exit: 1 Nov 2026 (T+90)
168 sharesCommon SharesTSXSEDI:4744611
Canonical exit: 29 Sept 2026 (T+90)
168 sharesCommon SharesTSXSEDI:4729080
Canonical exit: 30 Aug 2026 (T+90)
6 of 6 declarations
